# A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone

> **NCT00161564** · PHASE2 · WITHDRAWN · sponsor: **Weill Medical College of Cornell University**

## Conditions studied

- Idiopathic Thrombocytopenic Purpura (ITP)

## Interventions

- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT00161564
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2004-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00161564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00161564, "A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00161564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*